110 related articles for article (PubMed ID: 12489326)
21. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention.
Harwell JI; Brown RB
Chest; 2000 Feb; 117(2):530-41. PubMed ID: 10669700
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae].
Soriano F
Med Clin (Barc); 1999 Jun; 113(3):103-8. PubMed ID: 10464745
[No Abstract] [Full Text] [Related]
23. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece.
Maraki S; Mantadakis E; Samonis G
Chemotherapy; 2010; 56(4):325-32. PubMed ID: 20720416
[TBL] [Abstract][Full Text] [Related]
24. [Upper respiratory tract infections in the child: suppurative otitis. The microbiologist's point of view].
Murbach V
Presse Med; 2002 Nov; 31(37 Pt 2):S21-2; discussion S24. PubMed ID: 12489331
[No Abstract] [Full Text] [Related]
25. Question 3: can pneumonia caused by penicillin-resistant Streptococcus pneumoniae be treated with penicillin?
Clifford V; Tebruegge M; Vandeleur M; Curtis N
Arch Dis Child; 2010 Jan; 95(1):73-7. PubMed ID: 20040690
[No Abstract] [Full Text] [Related]
26. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
27. First report on multidrug-resistant non-encapsulated Streptococcus pneumoniae isolated from a patient with pneumonia.
Takeuchi N; Ohkusu M; Hishiki H; Fujii K; Hotta M; Murata S; Ishiwada N
J Infect Chemother; 2020 Jul; 26(7):749-751. PubMed ID: 32409019
[TBL] [Abstract][Full Text] [Related]
28. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
Davidson R; Cavalcanti R; Brunton JL; Bast DJ; de Azavedo JC; Kibsey P; Fleming C; Low DE
N Engl J Med; 2002 Mar; 346(10):747-50. PubMed ID: 11882730
[No Abstract] [Full Text] [Related]
29. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
[TBL] [Abstract][Full Text] [Related]
30. Efflux of novel quinolones in contemporary Streptococcus pneumoniae isolates from community-acquired pneumonia.
Lismond A; Carbonnelle S; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2011 Apr; 66(4):948-51. PubMed ID: 21393137
[No Abstract] [Full Text] [Related]
31. Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics.
Feldman C; Brink AJ; von Gottberg A; Wolter N; de Gouveia L; Perovic O; Klugman KP
Int J Antimicrob Agents; 2010 Jul; 36(1):95-7. PubMed ID: 20378315
[No Abstract] [Full Text] [Related]
32. Failure of pristinamycin treatment in a case of pneumonia caused by a streptogramins B-type resistant pneumococcus.
Brevet-Coupe F; Guerin B; Watine J
Scand J Infect Dis; 1998; 30(4):419-20. PubMed ID: 9817526
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy and safety of levofloxacin in low respiratory tract infection].
Zubkov MN
Antibiot Khimioter; 2004; 49(5):31-7. PubMed ID: 15573900
[No Abstract] [Full Text] [Related]
34. [Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Calvo A; Amores R; Valero E; Sevillano D; Prieto J;
Rev Esp Quimioter; 2001 Dec; 14(4):345-50. PubMed ID: 11856980
[TBL] [Abstract][Full Text] [Related]
35. [A new antibiotic against respiratory tract infections. More power against pneumococci].
MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
[No Abstract] [Full Text] [Related]
36. [Ways of improving the effectiveness of bacteriological diagnosis and treatment of nonspecific lung diseases].
Kozlova NV; Girshovich ES; Spirina TS
Antibiot Khimioter; 1990 Aug; 35(8):41-3. PubMed ID: 2264754
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
Jacobs MR
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
[TBL] [Abstract][Full Text] [Related]
38. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Lee WK; Young BW
J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
[No Abstract] [Full Text] [Related]
39. Doxycycline activity against Streptococcus pneumoniae.
Shea KW; Cunha BA; Ueno Y; Abumustafa F; Qadri SM
Chest; 1995 Dec; 108(6):1775-6. PubMed ID: 7497817
[No Abstract] [Full Text] [Related]
40. START learning by sharing: FAQs.
Rodvold KA
J Manag Care Pharm; 2009 Mar; 15(2 Suppl):S24-6. PubMed ID: 19236138
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
